Corpus Intelligence IC Memo — MONROE COUNTY MEDICAL CENTER 2026-04-26 09:39 UTC
IC Memo — MONROE COUNTY MEDICAL CENTER
Investment Committee Memorandum | KY | 49 beds | Grade D | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MONROE COUNTY MEDICAL CENTER

CCN 180105 | MONROE, KY | 49 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MONROE COUNTY MEDICAL CENTER is a 49-bed community hospital in MONROE, KY with $17.7M in net patient revenue and a -23.2% operating margin. The hospital serves a payer mix of 48.2% Medicare, 0.0% Medicaid, and 51.8% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -23.2% to -15.8% (+736bps).

Net Revenue HCRIS$17.7M
Current EBITDA COMPUTED$-4.1M
Operating Margin COMPUTED-23.2%
Occupancy HCRIS21.4%
Revenue / Bed COMPUTED$362K
Net-to-Gross HCRIS40.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
68
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -23.2% places it below the state median. Among 68 size-comparable peers (24-98 beds), the median margin is -0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 68 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MONROE COUNTY MEDICAL CENTER (Target)KY49$17.7M-23.2%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
CLARK REGIONAL MEDICAL CENTERKY54$156.4M16.5%
BAPTIST HEALTH RICHMONDKY53$145.6M-3.7%
GEORGETOWN COMMUNITY HOSPITALKY75$118.5M15.1%
TAYLOR REGIONAL HOSPITALKY90$109.9M-6.7%
HIGHLANDS REGIONAL MEDICAL CENKY63$96.5M-32.6%
JACKSON PURCHASE MEDICAL CENTEKY95$91.1M-6.8%
FLAGET MEMORIAL HOSPITALKY40$86.2M-0.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$372K+210bp18mo
Cost to Collect4.5%2.5%$355K+200bp12mo
Denial Rate Reduction12.0%6.5%$351K+198bp12mo
A/R Days Reduction5200.0%3800.0%$216K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$372K
Cost to Collect
$355K
Denial Rate Reduction
$351K
A/R Days Reduction
$216K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$-4.1M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$-2.8M
Current Margin-23.2%
Pro Forma Margin-15.8%
WC Released (1x)$680K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.3M$-14.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.3M$-17.5M0.00x-100.0%
Bull Case9.0x11.0x$-5.7M$-15.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.7M$-18.3M0.00x-100.0%
Bear Case11.0x10.0x$-7.0M$-18.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.0M$-22.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 21.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 68 hospitals with 24-98 beds
  • Same-state prioritization (n=69)
  • Comp margins: P25=-11.0% / P50=-0.8% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.